Literature DB >> 18550209

Clinicopathologic features and treatment outcomes in Woringer-Kolopp disease.

Juliette Lee1, Natalie Viakhireva, Christine Cesca, Percy Lee, Sabine Kohler, Richard T Hoppe, Youn H Kim.   

Abstract

Woringer-Kolopp disease, also known as pagetoid reticulosis, is an exceedingly rare variant of mycosis fungoides. Accurate diagnosis and effective treatment is essential to prevent progression to debilitating disease. We identified 7 patients with Woringer-Kolopp disease treated at our institution. We review the major clinical and pathologic characteristics of this disease, focusing on treatment strategies and patient outcomes. All of our patients were successfully treated with skin-directed therapies including topical steroids, topical nitrogen mustard, psoralen plus ultraviolet A, narrow-band ultraviolet B, and radiation therapy. Our observations confirm that Woringer-Kolopp disease carries an excellent prognosis, and support that the most effective and appropriate treatment for recalcitrant or severe Woringer-Kolopp disease is localized radiation therapy.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18550209     DOI: 10.1016/j.jaad.2008.04.018

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  3 in total

1.  CD8+ Pagetoid Reticulosis Presenting as a Solitary Foot Plaque in a Young Woman.

Authors:  Stephanie J Martin; Philip R Cohen; Jeong Hee Cho-Vega; Jaime A Tschen
Journal:  J Clin Aesthet Dermatol       Date:  2010-10

Review 2.  Mycosis fungoides and Sézary syndrome: clinical, histopathological and immunohistochemical review and update.

Authors:  Thamy Yamashita; Luciana Patricia Fernandes Abbade; Mariangela Esther Alencar Marques; Silvio Alencar Marques
Journal:  An Bras Dermatol       Date:  2012 Nov-Dec       Impact factor: 1.896

3.  Pagetoid Reticulosis: Report of Two Cases and Review of the Literature.

Authors:  Krista Larson; Mark R Wick
Journal:  Dermatopathology (Basel)       Date:  2016-03-04
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.